Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index.


Journal

Arthritis & rheumatology (Hoboken, N.J.)
ISSN: 2326-5205
Titre abrégé: Arthritis Rheumatol
Pays: United States
ID NLM: 101623795

Informations de publication

Date de publication:
04 2020
Historique:
received: 14 08 2019
accepted: 15 10 2019
pubmed: 22 10 2019
medline: 21 7 2020
entrez: 22 10 2019
Statut: ppublish

Résumé

The Systemic Lupus International Collaborating Clinics (SLICC) frailty index (FI) has been shown to predict mortality, but its association with other important outcomes is unknown. We examined the association of baseline SLICC FI values with damage accrual in the SLICC inception cohort. The baseline visit was defined as the first visit at which both organ damage (SLICC/American College of Rheumatology Damage Index [SDI]) and health-related quality of life (Short Form 36) were assessed. Baseline SLICC FI scores were calculated. Damage accrual was measured by the increase in SDI between the baseline assessment and the last study visit. Multivariable negative binomial regression was used to estimate the association between baseline SLICC FI values and the rate of increase in the SDI during follow-up, adjusting for relevant demographic and clinical characteristics. The 1,549 systemic lupus erythematosus (SLE) patients eligible for this analysis were mostly female (88.7%) with a mean ± SD age of 35.7 ± 13.3 years and a median disease duration of 1.2 years (interquartile range 0.9-1.5 years) at baseline. The mean ± SD baseline SLICC FI was 0.17 ± 0.08. Over a mean ± SD follow-up of 7.2 ± 3.7 years, 653 patients (42.2%) had an increase in SDI. Higher baseline SLICC FI values (per 0.05 increase) were associated with higher rates of increase in the SDI during follow-up (incidence rate ratio [IRR] 1.19 [95% confidence interval 1.13-1.25]), after adjusting for age, sex, ethnicity/region, education, baseline SLE Disease Activity Index 2000, baseline SDI, and baseline use of glucocorticoids, antimalarials, and immunosuppressive agents. Our findings indicate that the SLICC FI predicts damage accrual in incident SLE, which further supports the SLICC FI as a valid health measure in SLE.

Identifiants

pubmed: 31631584
doi: 10.1002/art.41144
pmc: PMC7113092
mid: NIHMS1055504
doi:

Substances chimiques

Immunosuppressive Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

658-666

Subventions

Organisme : NCRR NIH HHS
ID : M01 RR000046
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000150
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR025741
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001422
Pays : United States
Organisme : CIHR
ID : MOP-88526
Pays : Canada
Organisme : NIAMS NIH HHS
ID : P30 AR072579
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR043727
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR069572
Pays : United States
Organisme : NIAMS NIH HHS
ID : P60 AR064464
Pays : United States
Organisme : NIAMS NIH HHS
ID : K24 AR068406
Pays : United States
Organisme : NIAMS NIH HHS
ID : P60 AR048098
Pays : United States
Organisme : NIAMS NIH HHS
ID : K24 AR002138
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© 2019, American College of Rheumatology.

Références

Rheumatology (Oxford). 2004 Feb;43(2):202-5
pubmed: 12923289
Cancer. 2015 May 15;121(10):1540-7
pubmed: 25529481
J Am Geriatr Soc. 2006 Jun;54(6):975-9
pubmed: 16776795
CMAJ. 2005 Aug 30;173(5):489-95
pubmed: 16129869
Arthritis Rheum. 1999 Apr;42(4):599-608
pubmed: 10211873
Scand J Rheumatol. 2009 Mar-Apr;38(2):121-7
pubmed: 18991189
J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7):738-43
pubmed: 17634321
Arthritis Rheumatol. 2019 Aug;71(8):1297-1307
pubmed: 30771242
J Rheumatol. 2003 Sep;30(9):1955-9
pubmed: 12966597
J Infect Dis. 2014 Oct 15;210(8):1170-9
pubmed: 24903667
Lupus. 2008 Nov;17(11):1042-8
pubmed: 18852231
BMC Geriatr. 2008 Sep 30;8:24
pubmed: 18826625
Biogerontology. 2010 Oct;11(5):547-63
pubmed: 20559726
Lancet. 2013 Mar 2;381(9868):752-62
pubmed: 23395245
Arthritis Rheum. 2008 Mar;58(3):843-53
pubmed: 18311802
J Nutr Health Aging. 2012 Oct;16(10):903-7
pubmed: 23208030
AIDS. 2015 Aug 24;29(13):1633-41
pubmed: 26372273
J Rheumatol. 2014 Apr;41(4):698-705
pubmed: 24584923
CMAJ. 2011 May 17;183(8):E487-94
pubmed: 21540166
Blood. 2018 Feb 1;131(5):515-524
pubmed: 29141942
Interdiscip Top Gerontol. 2015;40:85-98
pubmed: 25341515
Expert Rev Pharmacoecon Outcomes Res. 2011 Aug;11(4):455-68
pubmed: 21831027
Interdiscip Top Gerontol Geriatr. 2015;41:66-73
pubmed: 26301980
Semin Arthritis Rheum. 2013 Dec;43(3):352-61
pubmed: 23786872
Arthritis Rheum. 1997 May;40(5):809-13
pubmed: 9153540
BMC Musculoskelet Disord. 2015 Aug 12;16:188
pubmed: 26264937
Lupus. 2001;10(2):93-6
pubmed: 11237132
Arthritis Rheum. 1996 Mar;39(3):363-9
pubmed: 8607884
Arthritis Rheum. 1997 Sep;40(9):1725
pubmed: 9324032
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
J Rheumatol. 2020 Jan;47(1):72-81
pubmed: 30988130
J Rheumatol. 2002 Jul;29(7):1398-400
pubmed: 12136895
J Rheumatol. 2002 Feb;29(2):288-91
pubmed: 11838846
Ann Rheum Dis. 2015 Sep;74(9):1706-13
pubmed: 24834926
Exp Gerontol. 2018 Jul 1;107:126-129
pubmed: 28847723
Age Ageing. 2012 Mar;41(2):142-7
pubmed: 22345294
J Am Geriatr Soc. 2005 Dec;53(12):2184-9
pubmed: 16398907
Lupus. 2015 Oct;24(12):1248-56
pubmed: 25957301
Arthritis Rheum. 2007 Jan;56(1):265-73
pubmed: 17195230
Lupus. 2019 Sep;28(10):1261-1272
pubmed: 31296137

Auteurs

Alexandra Legge (A)

Dalhousie University, Halifax, Nova Scotia, Canada.

Susan Kirkland (S)

Dalhousie University, Halifax, Nova Scotia, Canada.

Kenneth Rockwood (K)

Dalhousie University, Halifax, Nova Scotia, Canada.

Pantelis Andreou (P)

Dalhousie University, Halifax, Nova Scotia, Canada.

Sang-Cheol Bae (SC)

Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.

Caroline Gordon (C)

University of Birmingham College of Medical and Dental Sciences, Birmingham, UK.

Juanita Romero-Diaz (J)

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico City, Mexico.

Jorge Sanchez-Guerrero (J)

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico City, Mexico.

Daniel J Wallace (DJ)

Cedars-Sinai Medical Center and David Geffen School of Medicine at University of California, Los Angeles.

Sasha Bernatsky (S)

McGill University, Montreal, Quebec, Canada.

Ann E Clarke (AE)

University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.

Joan T Merrill (JT)

Oklahoma Medical Research Foundation, Oklahoma City.

Ellen M Ginzler (EM)

SUNY Downstate Medical Center, New York, New York.

Paul R Fortin (PR)

CHU de Quebec-Université Laval, Quebec City, Quebec, Canada.

Dafna D Gladman (DD)

Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada.

Murray B Urowitz (MB)

Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada.

Ian N Bruce (IN)

Arthritis Research UK Epidemiology Unit, University of Manchester, NIHR Manchester Musculoskeletal Biomedical Research Centre, and Manchester University NHS Foundation Trust, Manchester, UK.

David A Isenberg (DA)

University College London, London, UK.

Anisur Rahman (A)

University College London, London, UK.

Graciela S Alarcón (GS)

University of Alabama at Birmingham.

Michelle Petri (M)

Johns Hopkins University School of Medicine, Baltimore, Maryland.

Munther A Khamashta (MA)

St. Thomas Hospital and King's College London GKT School of Medical Education, London, UK.

M A Dooley (MA)

University of North Carolina at Chapel Hill.

Rosalind Ramsey-Goldman (R)

Northwestern University and Feinberg School of Medicine, Chicago, Illinois.

Susan Manzi (S)

Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, Pennsylvania.

Asad A Zoma (AA)

Hairmyres Hospital, East Kilbride, UK.

Cynthia Aranow (C)

Feinstein Institute for Medical Research, Manhasset, New York.

Meggan Mackay (M)

Feinstein Institute for Medical Research, Manhasset, New York.

Guillermo Ruiz-Irastorza (G)

Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain.

S Sam Lim (SS)

Emory University School of Medicine, Atlanta, Georgia.

Murat Inanc (M)

Istanbul University, Istanbul, Turkey.

Ronald F van Vollenhoven (RF)

Karolinska Institute, Stockholm, Sweden.

Andreas Jonsen (A)

Lund University, Lund, Sweden.

Ola Nived (O)

Lund University, Lund, Sweden.

Manuel Ramos-Casals (M)

Institut d'Investigacions Biomèdiques August Pi i Sunyer and Hospital Clínic, Barcelona, Barcelona, Spain.

Diane L Kamen (DL)

Medical University of South Carolina, Charleston.

Kenneth C Kalunian (KC)

University of California, San Diego School of Medicine.

Soren Jacobsen (S)

Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Christine A Peschken (CA)

University of Manitoba, Winnipeg, Manitoba, Canada.

Anca Askanase (A)

Hospital for Joint Diseases, New York University New York, New York.

John G Hanly (JG)

Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH